CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences Sep 25 2025 CAR T cells are patient-derived, genetically engineered immune cells. They are "living drugs" and constitute a milestone in modern medicine. Equipping T cells, a key cell type of the immune system, with a "chimeric antigen receptor" (CAR) enables them to specifically recognize and attack cancer cells. CAR T cell therapy has demonstrated its potential by curing patients with otherwise untreatable blood